A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Clinical trial NCT07142356 · RECRUITING

Trial details

NCT number: NCT07142356
Sponsor: Retension Pharmaceuticals. Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Uncontrolled Hypertension

Start date: 2025-10-31
Primary completion: 2026-10-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.